国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2014年
11期
1435-1436
,共2页
张春和%金艳%于桂军%赵增霞
張春和%金豔%于桂軍%趙增霞
장춘화%금염%우계군%조증하
半乳糖凝集素3%急性缺血性脑卒中%预后评估
半乳糖凝集素3%急性缺血性腦卒中%預後評估
반유당응집소3%급성결혈성뇌졸중%예후평고
galectin-3%acute ischemic stroke%prognosis
目的:研究半乳糖凝集素3对急性缺血性脑卒中患者预后评估的价值。方法选取165例急性缺血性脑卒中患者,追踪随访观察12个月,记录复发脑卒中事件的情况,并检测其血清半乳糖凝集素3的浓度。结果至随访截止,165例急性缺血性脑卒中患者中共有65例患者在12个月内再次发生脑卒中事件,复发率为39.39%。复发脑卒中患者的血清半乳糖凝集素3水平显著高于无复发的患者,差异有统计学意义(P <0.05)。半乳糖凝集素3高水平患者复发脑卒中的比例显著高于低水平患者,差异有统计学意义(P <0.05)。结论半乳糖凝集素3是预测急性缺血性脑卒中患者预后的良好指标,该指标的检测有助于对患者进行复发危险评估。
目的:研究半乳糖凝集素3對急性缺血性腦卒中患者預後評估的價值。方法選取165例急性缺血性腦卒中患者,追蹤隨訪觀察12箇月,記錄複髮腦卒中事件的情況,併檢測其血清半乳糖凝集素3的濃度。結果至隨訪截止,165例急性缺血性腦卒中患者中共有65例患者在12箇月內再次髮生腦卒中事件,複髮率為39.39%。複髮腦卒中患者的血清半乳糖凝集素3水平顯著高于無複髮的患者,差異有統計學意義(P <0.05)。半乳糖凝集素3高水平患者複髮腦卒中的比例顯著高于低水平患者,差異有統計學意義(P <0.05)。結論半乳糖凝集素3是預測急性缺血性腦卒中患者預後的良好指標,該指標的檢測有助于對患者進行複髮危險評估。
목적:연구반유당응집소3대급성결혈성뇌졸중환자예후평고적개치。방법선취165례급성결혈성뇌졸중환자,추종수방관찰12개월,기록복발뇌졸중사건적정황,병검측기혈청반유당응집소3적농도。결과지수방절지,165례급성결혈성뇌졸중환자중공유65례환자재12개월내재차발생뇌졸중사건,복발솔위39.39%。복발뇌졸중환자적혈청반유당응집소3수평현저고우무복발적환자,차이유통계학의의(P <0.05)。반유당응집소3고수평환자복발뇌졸중적비례현저고우저수평환자,차이유통계학의의(P <0.05)。결론반유당응집소3시예측급성결혈성뇌졸중환자예후적량호지표,해지표적검측유조우대환자진행복발위험평고。
Objective To evaluate the prognosis value of the expression of galectin 3 in patients with acute ischemic stroke. Methods 165 Patients with acute ischemic stroke had been observated for 12 months and their occurrence of recurrent stroke e-vents were recorded.The concentration of galectin-3 was detected.Results 65 patients had recurrence stroke events with a rate of 39.39% within 12 months.It was also found that the serum concentration of galectin-3 in acute ischemic stroke recurrence patients were significantly higher than those of patients without recurrence,the difference was statistically significant(P <0.05).The rate of acute ischemic stroke recurrence in patients with high concentrations of galectin-3 was higher than that in patients with low concen-trations of galectin-3,the difference was statistically significant(P <0.05).Conclusion Galectin-3 is a good indicator to predict the prognosis of patients with acute ischemic stroke,and it could be used to evaluate the risk of recurrence in patients.